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University/Aarhus University Hospital, DenmarkAlong with the improved treatment conformity achieved with these metrics plays an essential role in translating the obtained
the recently implemented radiotherapy (RT) planning and delivery
approaches [1], there is growing awareness of the uncertainties
connected to the deﬁnition and delineation of the RT targets as
well as the organs at risk (ORs). To assure accurate reproducibility
of the planned treatment in order to avoid ‘geographical miss’ of
the target, it is mandatory to correctly identify the volumes to be
irradiated and to appropriately manage these uncertainties in the
deﬁnition of the gross target volume (GTV) as well as of standard-
ized, disease-speciﬁc, nodal clinical target volumes (CTVs).
Accurate segmentation of primarily the GTVs and CTVs, as well
as the ORs, therefore represents the foundation for successful RT.
International or institutional guidelines, contouring atlases, case
libraries and numerous recommendations have thus recently been
developed [2–12]. Atlases and guidelines are widely recognized
and contribute to reducing inter-observer variability, but they are
static documents that also lack interactivity.
To address this challenge, several commercial auto-contouring
software solutions have recently been released, representing an
opportunity for individualizing the existing atlases, automatically
propagating clinically reliable contours to patients’ speciﬁc anato-
mies [13]. They also have potential for lowering the segmentation
time, increasing the adherence to existing guidelines and, not the
least, to reduce the inter-observer variability that still may be a
major source of uncertainty in RT. The current issue presents sev-
eral studies related to the use of such software in RT [14–16].
A basic requirement of the application of auto-segmentation
software is the existence of a widely recognized and reliable deﬁ-
nition of the volumes, according to the anatomical region, the his-
tology as well as the stage of the disease. This can be described as
software ontology [17], covering clinical, anatomical, pathological
and imaging information. This ontology should be linked to bench-
mark performance values obtained through comparisons with the
agreement between multiple observers/operators, or between
manual delineations and auto-contouring. There are several met-
rics for the agreement between the contours, and establishing
ranges indicating clinically acceptable agreement on the scales ofobservations to everyday practice.
In this paper we would like to share comments and criticisms
on how evidence can be derived from the use of auto-segmentation
software, addressing the key aspects that should be considered in
future studies in this ﬁeld: ontology deﬁnition, benchmark evalua-
tion methods and performance evaluation tools. We also discuss
the potential beneﬁts that can be achieved with these tools.Ontology deﬁnition
The term ontology refers to a form of dictionary where informa-
tion is speciﬁed and organized in a well-deﬁned semantic data col-
lection model; a set of concepts within a domain, and also the
relationships between those concepts. In the auto-contouring set-
ting the ontology is therefore represented by the prior reference
knowledge regarding GTV and CTV deﬁnition, in practise related
to the existence of contouring guidelines and the adherence to
these.
The segmentation of the GTV relies on interpretation of multi-
modal imaging data (e.g. CT, MRI, PET), often involving the use of
speciﬁc image registration and segmentation tools [18]. GTV seg-
mentation is frequently performed in close consultation with
other medical disciplines (e.g. radiologists, surgeons). Delineation
of the nodal CTV reﬂects the lymphatic drainage of the disease
site and its relapse risk, which are generally identiﬁed through
retrospective pathological and/or surgical observations performed
for the speciﬁc stage of disease. Prospective randomized studies
of the effect of lymph node irradiation, such as in the RTOG
9413 study of prostate cancer with or without pelvic irradiation
[19], still remains uncommon. Areas of nodal sub-volumes of
different risks (both for lymphatic spread and/or relapse) are gen-
erally described by contouring atlases (with related text descrip-
tions), deﬁning their boundaries and anatomical relations.
Together with the interpretation of the TNM stage of the disease
[20] the evaluation of nodal involvement will dictate which
sub-volumes should be included in the nodal CTV [2,3,5]. Reliable
deﬁnition and segmentation of the normal tissues has also con-
siderable dose/volume and clinical consequences, in particular
for dose-limiting ORs [21].
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(i.e. delineation guidelines) suggested, yet there are seldom any
criteria to deﬁne which represents the most accurate and clinically
reliable standard for each considered anatomical district. A ﬁrst
attempt of a hierarchical organization of these proposals was the
endorsement of the proposed contours by national and interna-
tional scientiﬁc societies but, having prostate as an example, at
least eight atlases with the endorsement of four different organisa-
tions can be counted today, demonstrating a substantial lack of
harmony [22–29].
Dealing with auto-contouring software, it is necessary to under-
stand how the auto-segmentation system propagates the chosen
ontology on the single case, e.g. by the adoption of a commonly
agreed atlas delineation by the institution’s organ oriented expert
team, or through the creation of an atlas through selection of cases
uploaded into a library system available in an atlas-based contour-
ing system [17,30].Performance evaluation tools
The performance of auto-segmentation software is usually eval-
uated with respect to contour similarity indices as well as potential
time/workload savings. So far a number of approaches have been
used to quantify the amount of similarity between the proposed
contours and others. Analysis and comparison among the ﬁve main
methods (area of intersection, Dice similarity index, Jaccard index,
Conformation number, Hausdorff distance) found that they are not
effective in distinguishing random from systematic errors, or to
separate false positives from false negatives [17,31–34]. They also
operate ‘‘out of context’’, without any consideration to the poten-
tial effects of a contouring error. What the measures do quantify
is how close a given contour is to an ‘ideal’ contour. This is suitable
for a ﬁrst level analysis and is useful as a comparison tool, espe-
cially if a combination of a dimensionless index and a measure
such as the Hausdorff distance is used; this is even more appropri-
ate if the attempted contour is sufﬁciently close to its reference.
The Dice index is linear with respect to the intersection, while
the other conformation indices are essentially non-linear, showing
instead a tendency to amplify the effect of a similar degree of dis-
crepancy when the intersection is larger. This does not pose any
problem (the monotonicity is assured), however, the non-unifor-
mity should have an adequate justiﬁcation from a clinical and/or
educational point of view.
A combination of conformation scores, metric elements and
clinical risk assessment could lead to a new class of indices, which
could prove useful at ﬁrst in an educational environment evaluat-
ing a ‘‘test’’ contour against a reference created by a domain expert.
Closely related to the benchmark contouring deﬁnition is the
measurement of the contouring time spent, to quantify the time
saved with the auto-segmentation approach. It is important to
measure the time spent during all components of the process,
and to include the time spent in the deﬁnition of the atlas cases
and in making the right atlas case choice (manual or automatic).Benchmark evaluation methods
So far only a few studies have described benchmark values in
various anatomical regions, often discussing these in relation to
the reduction in segmentation time [2–8,17]. These studies usually
compare the performance of auto-segmentation tools versus a ref-
erence segmentation delineated by one of more human observers.
In such settings, the agreement between multiple human segmen-
tations represents the benchmark value the auto-contoured
structures should be compared with.The auto-segmentation studies have reported Dice similarity
index values well below unity in all considered anatomical regions,
ranging from 0.67 to 0.79 in the anorectal region to 0.86–0.91 in
the breast [3]. These values should be evaluated relative to com-
parisons between contours drawn manually by experts, where
the existing variability shows similar values [6,17,32,35].
Struggling to obtain a complete overlap between two manually
contoured structures could therefore be deceptive and can lead to
dead-end streets in evaluating inter-observer studies, as the exis-
tence of a certain degree of variability will remain unavoidable in
daily clinical practice.
This translates into the necessity of building up a reliable ‘‘gold
structure set’’ which will represent the unique benchmark of the
study and will be the referral contour to which all other contours
should be compared with. There are several strategies that can
be followed when deﬁning these benchmark structures: a com-
monly agreed delineation by two or more operators with the same
expertise; a gold contour coming from the experience of one highly
skilled physician or from a team of experts of the chosen anatom-
ical district. Each of these strategies has its own pros and cons:
trusting a single operator for the gold contour delineation is quick
and easy but lacks the fundamental independent cross check of the
structures with other operators, while enrolling a team of experts
represents a heavier effort but it could offer a more reliable
segmentation.Discussion
The issues covered in the three previous sections can be sum-
marized into a set of recommendations (Table 1) that should be
considered in future studies of auto-segmentation issues.
The beneﬁts expected from the use of auto-contouring soft-
ware are several, and cover aspects related to clinical impact,
the resulting dose distributions as well as education. The correct
deﬁnition of RT targets and ORs has direct clinical consequences,
with respect to both disease control and toxicity. In particular the
contouring of nodal CTV sub-volumes is critical, and auto-con-
touring software can be very useful for this purpose. This is also
related to the increasing importance of correlating CTV sub-vol-
umes (and critical choices in this setting) with (imaging) data of
local control and survival [36]. Such studies will provide essential
information on which structures to include in the auto-contouring
atlases and templates. This information is also key input to indi-
vidualized and adaptive approaches to prediction databases and
models [37,38].
Auto-contouring software has clearly a potential to play an
important role in future RT, based on sound clinical evidence
and linking survival to volume choice and their automatic propa-
gation. However, building up clinical evidence is time consuming
(not the least within a prospective setting), and there are consid-
erable future challenges in constructing reliable predictive models
[39–41]. Quantifying the potential clinical beneﬁts of auto-con-
touring in a retrospective way could be a ﬁrst step in this direc-
tion. In any case it should be underlined that present auto-
contouring tools are merely a supplementary instrument that
should be used together with careful manual editing of the pro-
posed structures.
Besides the simple geometrical comparison, it is useful to
explore the relation between auto-segmentation and dose/volume
parameters relating to target dose coverage and/or normal tissue
irradiation. Voet et al. [42] recently observed that moderate geo-
metrical differences in the PTV may have a large dosimetric
impact on the target. Speciﬁcally, they observed reductions in
D99 up to 11 Gy even for Dice coefﬁcients higher than 0.8 and
mean contour distances lower than 1 mm between the autocon-
Table 1
Recommendations for studies of auto-contouring software in radiotherapy.
Domain Recommendations
Ontology  A reliable ontology must always be described in details, specifying:
– the chosen delineation guidelines
– the applied selection/ﬁltering criteria
– anatomical and pathological information about the atlas patients selection (for example TNM, tumour site, patient’s gender, BMI)
 Describe in the patients’ library presentation the chosen structures, target or ORs and clearly report them in the paper
 Deﬁne and describe the adopted propagation method, underlining its pro and cons
Evaluation  Choose a time measurement unit for all the phases of the research that could allow a swift, friendly, comprehension by the reader, avoiding
unnecessary calculations.
 Report the reasons of the choice of the similarity indices describing their characteristics, nature and mathematical aspects
 Consider the different indices categories, bearing in mind that the use of only one kind of index would heavily limit the descriptive and statistical
power of the study
 Describe the existing contouring variability from different points of view, using of a combination of multiple different tools
Benchmark  Describe how the gold contour has been achieved, specifying if:
– realized deﬁning a mean contour among those segmented by the single components of the contouring group
– delineated only once with the common agreement of all operators
– result of a mutual independent check by the involved operators
– result of a test between the delineations proposed by the various operators and a master contour
 Illustrate the degree of expertise of the different operators involved in the benchmark deﬁnition describing contouring reference group compo-
sition, technical skills and scientiﬁc background
 Avoid implicit assumptions of a common expertise, knowledge, attitude and imaging interpretation skills among the reference group members
 Report speciﬁc imaging techniques chosen for delineation purposes (when used)
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issue, Jameson and colleagues showed how target delineation
uncertainties can also be transformed into tumour control proba-
bility predictions [14]. Also in this issue, Conson et al. reported on
the dose/volume effects of the use of auto-segmentation for nor-
mal tissues in the brain [15]. It is therefore necessary to develop
this ﬁeld further to fully describe the existing correlation between
the considered similarity indices and dose/volume effects [43].
This must still be considered along with what we refer to as the
‘‘benchmark trap’’ [17]: are we conﬁdent that the daily ‘‘human’’
inter-observer variability could show better performances, in
terms of dose and volumes, when considering a comparison with
the same manual benchmark? Further studies are required in
order to characterize the clinical beneﬁt with respect to dose/vol-
ume endpoints.
Another component of the beneﬁt offered by the use of auto-
contouring software is within the educational dimension, allowing
an improvement of the adherence to contouring guidelines for per-
sonnel in training, reducing the inter/intra-observer variability and
improving the reliability of contouring. Residents/trainees actually
learn how to segment using paper atlases, consulting guidelines or
referring directly to older and more experienced personnel. The
use of auto-contouring software can represent a useful, efﬁcient
and smart educational tool, offering in the meanwhile the chance
to test oneself with expert drawn structure sets, describing ones
learning curve and objectively measuring it through the calculation
of the available similarity indices.
In conclusion, auto-segmentation tools represent an attractive
opportunity with potentials for both reducing segmentation time
and increasing the adherence to existing guidelines. However, they
need to be carefully implemented and validated in daily clinical
practice. For such studies, we have presented a set of recommenda-
tions with regard to the ontology deﬁnition, performance evalua-
tion tools and benchmark evaluation methods to contribute in
the process of establishing useful clinical evidence from studies
in this ﬁeld.Declaration of interest
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